戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 frequent transitions predict the severity of autism.
2 ues to treat bone fractures in children with autism.
3 ccessfully classify patients with or without autism.
4  involvement of hundreds of gene variants in autism.
5 tically characterizing more complex cases of autism.
6 w studies have detailed the basal ganglia in autism.
7 ork for the early, post-natal development of autism.
8 of spine abnormalities being associated with autism.
9 equently related to other conditions besides autism.
10 offspring (F2) would be at increased risk of autism.
11 a loss of function in the pathophysiology of autism.
12  is altered in psychiatric disorders such as autism.
13 ss of functional FMRP, is a leading cause of autism.
14 man disorders, including CHARGE syndrome and autism.
15 mpairment in schizophrenia and some forms of autism.
16 of this reciprocity is a cardinal symptom of autism.
17 at are independently predictive of diagnosed autism.
18 ther symptoms including disordered sleep and autism.
19 nomonically impaired in children affected by autism.
20 e form of intellectual impairment, including autism.
21  >4,700 cancer genomes and genes involved in autism.
22 e repetitive movements and limbic changes of autism.
23 rks is "idiosyncratic" in an individual with autism.
24 vior and is implicated in social symptoms of autism.
25 therapeutic intervention in individuals with autism.
26 idence of specific learning disabilities and autism.
27 orders as epilepsy, Alzheimer's disease, and autism.
28  movement disorder, developmental delay, and autism.
29 ood and risk of developing schizophrenia and autism.
30 ed with symptom severity in individuals with autism.
31 ay bear relevance to synaptic dysfunction in autism.
32 ays for 106 individuals with low functioning autism (87 boys, 14.77 +/- 3.11 years) for 0.5-6 years (
33 e novo putative loss-of-function variants in autism-affected families, ALoFT distinguishes between de
34 g schizophrenia, bipolar disorder, epilepsy, autism, Alzheimer's disease, and Parkinson's disease, an
35                            Polygenic risk of autism and ADHD is associated with number of children.
36 f neurodevelopmental disorders, particularly autism and attention-deficit hyperactivity disorder.
37 ing the monitoring of disease states such as autism and chronic diseases involving oxidative stress t
38 europeptide Y+ neurons between subjects with autism and controls.
39 rovide insight into the early development of autism and have shown that characteristic social deficit
40 ween 2 striatal pathways in a mouse model of autism and indicate that the indirect striatal pathway d
41             Bipolar disorder, schizophrenia, autism and intellectual disability are complex neurodeve
42  the same region is strongly associated with autism and is less common in schizophrenia cases than in
43 naptic cell-adhesion molecules implicated in autism and other neuropsychiatric disorders.
44 inical disorders, including psychopathy, and autism and schizophrenia spectrum disorders, have been l
45 the context of psychiatric disorders such as autism and schizophrenia, a new promising pharmaceutical
46 ociated with neurological disorders, such as autism and schizophrenia, this signaling cascade offers
47 diseases including brain trauma, epilepsies, autism and schizophrenia.
48 mber variations of which are associated with autism and schizophrenia.
49 ia, including obsessive-compulsive disorder, autism, and alcoholism, occur more frequently in ALS kin
50 ng attention deficit/hyperactivity disorder, autism, and schizophrenia.
51 ngth and is relevant to learning and memory, autism, and sensitization to cocaine; however, the mecha
52  strongly implicated as a monogenic cause of autism, and Shank3 mutant mice show repetitive grooming
53 nes associated with intellectual disability, autism, and/or epilepsy were identified: 2p16.1-p15 dupl
54 hieved 84% and 81% accuracies for predicting autism- and Parkinson's-implicated genes, respectively,
55 depression, schizophrenia, bipolar disorder, autism, anxiety and attention deficit/hyperactivity diso
56 s that Fragile X syndrome and other types of autism are associated with immune system defects.
57 e demonstrated that the defining features of autism are not present in the first year of life but eme
58                       We discovered that one autism-associated de novo mutation in TGEF1 (K1431M), at
59 avior due to knockout of Nrxn1, an analog of autism-associated gene NRXN, exhibited marked LA-MeA def
60 and nucleus ambiguus (nAmb) that express the autism-associated MET receptor tyrosine kinase.
61  systematically examined the effect of three autism-associated mutations, the neuroligin-3 knockout,
62 we found that adult male mice expressing the autism-associated SERT Ala56 variant have altered centra
63 15 high-risk infants who were diagnosed with autism at 24 months.
64 g to neurodevelopmental disorders, including autism, attention-deficit/hyperactivity disorder, and sc
65 ities selective for oxytocin nonapeptide, an autism biomarker, were designed.
66 e variants that predispose to schizophrenia, autism, bipolar disorder, major depression and attention
67 hat there is a link between synaesthesia and autism but the nature of that link remains poorly charac
68 eurodevelopmental endophenotype not only for autism, but also for population-wide variation in social
69      Mutations in neuroligin-3 predispose to autism, but how such mutations affect synaptic function
70 n neuroligin genes have been associated with autism, but the cellular functions of different neurolig
71  Studies of infants at high familial risk of autism can provide insight into the early development of
72  development in infants later diagnosed with autism, characterized by cortical surface area hyper-exp
73 re differentially decreased in children with autism (chi(2) = 64.03, P < 0.0001).
74  volume variability, although independent of autism diagnosis.
75               Of the 12 RRBs measured by the Autism Diagnostic Interview-Revised, seven were found to
76           We also found correlations between Autism Diagnostic Observation Schedule scores and the de
77 airments in social affect as measured by the Autism Diagnostic Observation Schedule.
78 y cued to look at the eyes, 2-year-olds with autism did not look away faster than did typically devel
79  X syndrome (FXS), the most common heritable autism disorder.
80                            TSC patients with autism display impairments in white matter integrity.
81    Importantly, several mutations that cause autism disrupt this process.
82 velopmental brain and behavior mechanisms in autism during infancy, a period which precedes the emerg
83 are monogenic syndromes highly comorbid with autism - fragile X and tuberous sclerosis types 1 and 2
84 These differences become more pronounced for autism genes (p = 1.8 x 10(-3), OR = 2.2).
85  the Simons Simplex Collection (SSC) and the Autism Genetic Resource Exchange (AGRE) cohorts of child
86 g into account the familial structure of the Autism Genetic Resource Exchange data, we then determine
87 ges and opportunities for the translation of autism genetics knowledge into clinical practice.
88 m two of the largest ASD family cohorts, the Autism Genetics Resource Exchange and Autism Genome Proj
89  pleiotropy are pervasive characteristics of autism genetics.
90 s, the Autism Genetics Resource Exchange and Autism Genome Project (AGP).
91 was adopted to examine two groups (16 in the autism group and 15 in the control group) of Chinese chi
92                      Children suffering from autism have been reported to have low bone mineral densi
93 ies reveal that tonal language speakers with autism have enhanced neural sensitivity to pitch changes
94 istic probands, who are at elevated risk for autism, have demonstrated that the defining features of
95 ar, one variant identified in a patient with autism, human GluN2B S1415L, displayed reduced surface e
96 k of ASD and intellectual disability without autism (ID).
97 ological activation may increase the risk of autism in the child.
98                        Of 1624 patients with autism included in this study, 1299 were boys (80%) and
99 ome (FXS), a major disorder characterized by autism, intellectual disability, hyperactivity, and seiz
100 ith severe ASD who were treated at Ontario's Autism Intervention Program.
101 IRR, 9.45; 95% CI, 5.64-14.69) and childhood autism (IRR, 8.94; 95% CI, 3.21-19.23).
102                                              Autism is a prevailing neurodevelopmental disorder with
103                     Higher polygenic risk of autism is associated with fewer children and older age a
104 xpanding number of genes that are mutated in autism is showing us how imbalances in fundamental cellu
105 ause a frequent and highly penetrant type of autism linked to increased gene dosages of UBE3A, which
106 members and helped rationalize the impact of autism-linked mutations.
107         Recently, we characterized a de novo autism-linked UBE3A mutant (UBE3A(T485A)) that disrupts
108 ivo knockdown or conditional knockout of the autism-linked ubiquitin ligase RNF8 or associated ubiqui
109 auses of neurodevelopmental diseases such as autism, linking genetic association studies to specific
110 fied as persons with schizophrenia (N=3540), autism (N=16 146), attention-deficit/hyperactivity disor
111 ocial cues for eye-looking, 2-year-olds with autism neither shifted their gaze away nor more subtly a
112 ich have been reported to be associated with autism, Parkinson's disease and schizophrenia, respectiv
113 projection neurons, as a potential locus for autism pathology.
114 ysfunctions could contribute to nonsyndromic autism pathophysiology using induced pluripotent stem ce
115 tative behavioral traits associated with the autism phenotype.
116                      Individuals with higher Autism Quotient (AQ) scores cooperated less than subject
117 ly cited to explain a diagnostic hallmark of autism: reduced attention to others' eyes.
118 ychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P =
119  the identification of genes associated with autism, research emerging within the past two decades su
120 me, the most common known monogenic cause of autism, results from the loss of FMR1, a conserved, ubiq
121 th new observations from genetically defined autism risk alleles and rodent model, these findings sug
122 2000-2007 who were enrolled in the Childhood Autism Risks from Genetics and the Environment (CHARGE)
123 d found that three variants in patients with autism (S1415L) or schizophrenia (L1424F and S1452F) (S1
124 sociated with psychiatric conditions such as autism, schizophrenia, and posttraumatic stress disorder
125 esents a sensory filter that is disrupted in autism, schizophrenia, and several other mental disorder
126 sons of cognition, adaptive functioning, and autism severity scores between these groups demonstrated
127                               Theoretically, autism should be underpinned by aberrant brain dynamics.
128 The MMR and ITPC data from the children with autism showed evidence for lack of categorical perceptio
129  potential cause of tactile defensiveness in autism.SIGNIFICANCE STATEMENT We use a novel paradigm of
130 being a common complaint in individuals with autism, specific sleep phenotypes and their relationship
131  a recently introduced diagnostic feature of autism spectrum conditions (ASC).
132 er risk for intellectual disability (ID) and autism spectrum disorder (ASD) and affects an estimated
133                     Clinical overlap between autism spectrum disorder (ASD) and attention-deficit/hyp
134 mmon monogenic and highly penetrant cause of autism spectrum disorder (ASD) and intellectual disabili
135                                              Autism spectrum disorder (ASD) and obsessive-compulsive
136           We sequenced 689 participants with autism spectrum disorder (ASD) and other developmental a
137 s neurodevelopmental disorders, particularly autism spectrum disorder (ASD) and schizophrenia (SCZ).
138 psychiatric disorders with high comorbidity: autism spectrum disorder (ASD) and Tourette syndrome (TS
139                                              Autism spectrum disorder (ASD) describes a group of neur
140 eviously reported that infants who developed autism spectrum disorder (ASD) had increased cerebrospin
141                     Genetic risk factors for autism spectrum disorder (ASD) have yet to be fully eluc
142 the association between maternal smoking and autism spectrum disorder (ASD) in offspring have produce
143                         The core symptoms of autism spectrum disorder (ASD) include impaired social c
144                                              Autism spectrum disorder (ASD) is 2 to 5 times more comm
145                                              Autism spectrum disorder (ASD) is a behaviorally defined
146                                              Autism spectrum disorder (ASD) is a complex neurodevelop
147                                              Autism spectrum disorder (ASD) is a developmental disabi
148                                              Autism spectrum disorder (ASD) is a developmental disord
149                                              Autism spectrum disorder (ASD) is a heterogeneous group
150                                              Autism spectrum disorder (ASD) is a neurodevelopmental d
151                                              Autism spectrum disorder (ASD) is associated with physio
152                                              Autism spectrum disorder (ASD) is characterized by ritua
153                                              Autism spectrum disorder (ASD) is characterized by socia
154                                              Autism spectrum disorder (ASD) is frequently associated
155                                              Autism spectrum disorder (ASD) is known to be more preva
156         Data indicate that the prevalence of autism spectrum disorder (ASD) may be increasing and tha
157  dysfunction and the high male prevalence in autism spectrum disorder (ASD) remain poorly understood.
158                                              Autism spectrum disorder (ASD) risk is influenced by com
159                             Individuals with Autism Spectrum Disorder (ASD) seem to have difficulties
160 ing whole-genome sequencing of families with autism spectrum disorder (ASD) to build a resource (MSSN
161 rrently, there is no effective treatment for autism spectrum disorder (ASD), a developmental disabili
162 tor MEF2C regulates multiple genes linked to autism spectrum disorder (ASD), and human MEF2C haploins
163 bility (ID) and are strongly associated with autism spectrum disorder (ASD), attention deficit hypera
164 change are among the diagnostic criteria for autism spectrum disorder (ASD), but little research has
165 hannel NaV1.2 are important risk factors for autism spectrum disorder (ASD), developmental delay, and
166 n in at least a subgroup of individuals with autism spectrum disorder (ASD), including in those with
167                             Individuals with autism spectrum disorder (ASD), including those who othe
168 pmental process are seen in individuals with autism spectrum disorder (ASD), schizophrenia and intell
169   Fine motor skill impairments are common in autism spectrum disorder (ASD), significantly affecting
170                                       Within autism spectrum disorder (ASD), some work has used pupil
171 rce Exchange (AGRE) cohorts of children with autism spectrum disorder (ASD), we find strong statistic
172 nal disturbances are common in children with autism spectrum disorder (ASD), we sought to define the
173 ioral phenotypes.SIGNIFICANCE STATEMENT Many autism spectrum disorder (ASD)-linked mutations disrupt
174                  Recent studies suggest that autism spectrum disorder (ASD)-related behavioral phenot
175 to increase the risk for children to develop autism spectrum disorder (ASD).
176 ANK3 gene have been associated with risk for autism spectrum disorder (ASD).
177 ring pregnancy is known to increase risk for autism spectrum disorder (ASD).
178 to maternal FA and pesticides in relation to autism spectrum disorder (ASD).
179 tic development, but functions atypically in autism spectrum disorder (ASD).
180  the regulation of glutamatergic synapses in autism spectrum disorder (ASD).
181 mplicate the serotonin transporter (SERT) in autism spectrum disorder (ASD).
182  few studies have examined associations with autism spectrum disorder (ASD).
183 on in neuropsychiatric conditions, including autism spectrum disorder (ASD).
184 d 5-HT levels and may influence the risk for autism spectrum disorder (ASD).
185 ntifying phenotype-genotype relationships in autism spectrum disorder (ASD).
186 1A) gene was implicated as a risk factor for autism spectrum disorder (ASD).
187 der with comparatively high co-occurrence of autism spectrum disorder (ASD).
188 y factor influencing perceptual abilities in autism spectrum disorder (ASD).
189 ciated with intellectual disability (ID) and autism spectrum disorder (ASD).
190 ical frequency ranges develops atypically in autism spectrum disorder (ASD).
191 PTEN is mutated in a subset of children with autism spectrum disorder (ASD); however, the mechanism b
192 h improved outcomes for children with severe autism spectrum disorder (ASD); however, there are long
193 tational age (OR, 1.01 [95% CI, 0.81-1.25]), autism spectrum disorder (HR, 0.83 [95% CI, 0.62-1.13]),
194 was somewhat elevated for ADHD with comorbid autism spectrum disorder (OR, 1.76; 95% CI, 1.37-2.26).
195 4), anencephaly (AOR 2.9, 95% CI: 1.0, 8.2), autism spectrum disorder [AOR 1.3, 95% credible interval
196 npatient or outpatient clinical diagnosis of autism spectrum disorder and attention-deficit/hyperacti
197 ain comorbid developmental conditions (i.e., autism spectrum disorder and congenital malformations),
198  gene previously found to be associated with autism spectrum disorder and epilepsy.
199 id-pregnancy serum samples: association with autism spectrum disorder and intellectual disability.
200 and provide insight into the pathogenesis of autism spectrum disorder and intellectual disability.
201 h interactive domain 1B (ARID1B) gene causes autism spectrum disorder and intellectual disability; ho
202 robiota to neurobehavioral diseases, such as autism spectrum disorder and major depression, drawing u
203                                  People with autism spectrum disorder and other neurodevelopmental di
204 d in synaptic homoeostasis are implicated in autism spectrum disorder and sleep-wake control.
205        Exclusion of ADHD cases with comorbid autism spectrum disorder attenuated but did not explain
206 d a weak but significant association between autism spectrum disorder diagnosis and increased cerebel
207 ought to determine a combined effect size of autism spectrum disorder diagnosis on different measures
208 estational age OR, 1.15 [95% CI, 1.06-1.25]; autism spectrum disorder hazard ratio [HR], 2.02 [95% CI
209                                        Child autism spectrum disorder identified after the age of 2 y
210 red with no exposure was not associated with autism spectrum disorder in the child.
211  has been associated with increased risk for autism spectrum disorder in the offspring.
212                             The male bias in autism spectrum disorder incidence is among the most ext
213                                              Autism spectrum disorder is a debilitating condition wit
214           The description of such changes in autism spectrum disorder may clarify pathomechanisms and
215 een unequivocally linked to diseases such as autism spectrum disorder or epilepsy.
216 een described in individuals presenting with autism spectrum disorder or mild intellectual disability
217 al stage, stronger genetic links with either autism spectrum disorder or schizophrenia.
218                 The neuroanatomical bases of autism spectrum disorder remain largely unknown.
219 nsight into the neural substrates underlying autism spectrum disorder social symptom severity, and fu
220 mpared with unexposed siblings (incidence of autism spectrum disorder was 3.40 per 1000 person-years
221                             The incidence of autism spectrum disorder was 4.51 per 1000 person-years
222 vious observations of a higher risk of child autism spectrum disorder with serotonergic antidepressan
223 ed together in typical and atypical (notably autism spectrum disorder) groups: imitation, biological
224 f syndromic intellectual disability (ID) and autism spectrum disorder, and somatic mutations are link
225 populations - specifically, individuals with autism spectrum disorder, ASD - may further illuminate s
226 tric and neurodegenerative diseases, such as autism spectrum disorder, depression and Alzheimer's dis
227 higher rates than UK controls of symptoms of autism spectrum disorder, disinhibited social engagement
228 ificantly enriched for genes associated with autism spectrum disorder, giving support to the idea tha
229 omatin-remodeling subunit, in short stature, autism spectrum disorder, intellectual disability, and c
230 ity in the etiology across schizophrenia and autism spectrum disorder, PVI circuits are altered in th
231 oter, enriched in subgroups of children with autism spectrum disorder, reduces transcription and disr
232 es of many neurological disorders, including autism spectrum disorder, schizophrenia, and Alzheimer's
233 it/hyperactivity disorder, eating disorders, autism spectrum disorder, substance use disorders, anxie
234 mutations have recently been associated with autism spectrum disorder, which parallels previous evide
235 fficulties that enhance the understanding of autism spectrum disorder- and schizophrenia-related dime
236 been linked to neurological diseases such as autism spectrum disorder.
237 me, epilepsy, major depressive disorder, and autism spectrum disorder.
238 ocial signal was altered in individuals with autism spectrum disorder.
239 cluding schizophrenia, bipolar disorder, and autism spectrum disorder.
240 attention-deficit/hyperactivity disorder and autism spectrum disorder.
241 ation increases the likelihood of developing autism spectrum disorder.
242 sability, and the most common known cause of autism spectrum disorder.
243 n deficit/hyperactivity disorder (ADHD), and autism spectrum disorder.
244 ly presents with intellectual disability and autism spectrum disorder.
245 rapies to help ameliorate social deficits in autism spectrum disorder.
246 area affected in both fragile X syndrome and autism spectrum disorder.
247  many neurodevelopmental disorders including autism spectrum disorder; however, little is known about
248                                              Autism spectrum disorders (ASD) and attention-deficit/hy
249 n are part of the phenotypic overlap between autism spectrum disorders (ASD) and schizophrenia.
250                                              Autism spectrum disorders (ASD) are characterized by imp
251                                              Autism spectrum disorders (ASD) are common, complex and
252                Over 70% of the children with autism spectrum disorders (ASD) are positive for these a
253             The number of diagnosed cases of Autism Spectrum Disorders (ASD) has increased dramatical
254 nly implicated factors in neurodevelopmental autism spectrum disorders (ASD), characterized, in part,
255 tor 5 (mGluR5) have therapeutic potential in autism spectrum disorders (ASD), including tuberous scle
256  the neurodevelopmental deficits observed in autism spectrum disorders (ASD).
257 Risk (HR or LR, respectively) for developing Autism Spectrum Disorders (ASD).
258 eurotypical adults and may increase risk for autism spectrum disorders (ASD).
259 rome (FXS) is the leading monogenic cause of autism spectrum disorders (ASD).
260                                              Autism spectrum disorders (ASDs) and obsessive compulsiv
261 have been described in some individuals with autism spectrum disorders (ASDs) as well as their family
262 een prenatal exposure to antidepressants and autism spectrum disorders (ASDs) in children, with incon
263            The male bias in the incidence of autism spectrum disorders (ASDs) is one of the most nota
264 coding polymorphism has been associated with autism spectrum disorders (ASDs) within a subgroup of pa
265 sory hypersensitivity is a common symptom in autism spectrum disorders (ASDs), including fragile X sy
266 itrk5 and Shank3, reported models of OCD and autism spectrum disorders (ASDs).
267 ne product E6AP protein is a common cause of autism spectrum disorders (ASDs).
268 ining 1 (PTCHD1) is mutated in patients with autism spectrum disorders and intellectual disabilities
269 hat these rearrangements are associated with autism spectrum disorders and mirror phenotypes of obesi
270                This pattern was strongest in autism spectrum disorders and schizophrenia, and weakest
271 human Shank copy number variations (CNVs) on Autism spectrum disorders and schizophrenia.
272 tiple neurodevelopmental disorders including autism spectrum disorders and schizophrenia.
273 ed clusters for enrichment of schizophrenia, autism spectrum disorders, developmental delay and intel
274 tive immune system function is implicated in autism spectrum disorders, including Fragile X syndrome.
275 ation carriers from mothers of children with autism spectrum disorders, the comparison group.
276 understanding of the complex neurobiology of autism spectrum disorders, valid disease models are pivo
277  translation of dyrk1a, a Down syndrome- and autism spectrum disorders-related gene, is dependent on
278 standing DA developmental conditions such as autism spectrum disorders.
279 d to human hyperekplexia/startle disease and autism spectrum disorders.
280 es or contribute to the pathogenesis of some autism spectrum disorders.
281 ritable cause of intellectual disability and autism spectrum disorders.
282 s neuromotor deficits in startle disease and autism spectrum disorders.
283 ctions with central molecular hubs linked to autism spectrum disorders.
284 ar disease states such as CHARGE syndrome or autism spectrum disorders.
285 eneration of epilepsy, neuropathic pain, and autism spectrum disorders; thus, it is important to char
286                                      The AQ (Autism-Spectrum Quotient) scores were elevated in the sy
287 ta were collected in 86 2-year-olds: 26 with autism, tested at initial diagnosis; 38 matched typicall
288  cellular bone phenotype in a mouse model of autism that can be further utilized to investigate thera
289       Here we have utilized a mouse model of autism that duplicates 6.3 Mb region of chromosome 7 (Dp
290  epilepsy, intellectual disability and often autism; the most frequently occurring mutation is G70S.
291 gh ubiquitin ligases have been implicated in autism, their roles and mechanisms in brain development
292 e utilized the Shank3B mutant mouse model of autism to investigate how Shank3 mutation may differenti
293 ng from neurodevelopmental disorders such as autism to neurodegenerative disorders such as Alzheimer'
294  interaction of psychopathic tendencies with autism traits was associated with a decrement in perform
295 hat correlate with individual differences in autism traits, as measured by the SRS.
296 eness Scale (SRS), a quantitative measure of autism traits.
297       Here we characterize brain dynamics in autism using an energy-landscape analysis applied to res
298  with damaging DNMs in probands with CHD and autism was also found.
299  pattern for speech and nonspeech stimuli in autism was due to a speech-specific deficit in categoric
300 theses about abnormal neural computations in autism, with an emphasis on hypotheses regarding potenti

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top